Pharmaceutical News

New First-Line Treatment Approved in Europe for a Specific Type of Advanced Colon Cancer

/ June 28, 2026

The European Commission has approved a new treatment option for adults with a specific type of advanced colon cancer that […]

/ June 27, 2026

Agomab Therapeutics has designed a new Phase 2b clinical trial called NOV-ERA to test its experimental drug, ontunisertib, for treating

/ June 26, 2026

A new clinical trial has started to test a potential treatment for a common type of lung cancer. Racura Oncology

/ June 24, 2026

The National Institute for Health and Care Excellence (NICE) has approved a new combination treatment for adults with untreated multiple

/ June 23, 2026

Sandoz, a major pharmaceutical company, has opened its first of three major new facilities in Slovenia by launching a $99

/ June 22, 2026

Recipharm, a company that helps other drug companies manufacture their medicines, is investing millions of dollars to expand its operations

/ June 21, 2026

Hello! I’m a pharmacist, and I want to explain GlobalData’s privacy policy in a way that’s easy to understand. This

/ June 20, 2026

Right now, many biotech manufacturers are making important decisions about their production based on lab results that are two hours

/ June 19, 2026

Before you use our website, services, or any AI-powered tools we offer, please take a moment to read and understand

/ June 17, 2026

Johnson & Johnson has announced that Talvey (also known as talquetamab) has been approved by the Scottish Medicines Consortium (SMC)